Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...
Young, urban and poor women in Puerto Rico are highly vulnerable to substance dependency and suffer most in the opioid crisis ...
Department of Health and Human Services officials expected most of the agency’s roughly 5,200 probationary employees to be ...
A committee of experts that advises the Centers for Disease Control and Prevention is critical in setting national vaccine ...
Mario Paredes, general director of SOMOS Community Care, proclaims, is in tune with Pope Francis: “No to deportations! Yes to ...
Chowhound on MSN50m
Everything You Need To Know About RosehipsRosehips not only look pretty in your garden, but they are also delicious and good for you. Check out our guide to find out ...
On the political front, Robert F. Kennedy Jr. will become the next HHS secretary after he attained a majority of Senate votes ...
Mankind Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Royalty Income for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has ...
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 21,829.91 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback